Chao Nonprofit Featured in Los Angeles Business Journal

The Fight Against Cardiovascular Disease: Los Angeles County Takes a Stand with Derek Chao of Optum West

Derek Chao, MD, CEO of Optum West, is taking a stand against cardiovascular disease in Los Angeles County by supporting the American Heart Association’s mission to improve health and ensure an optimistic future for all. As chairperson of the 2024 Greater Los Angeles Heart and Stroke Walk, Dr. Chao is leading the charge to raise awareness and funds to combat heart disease and stroke, the top causes of death in the US and worldwide.

The Heart and Stroke Walk, held annually at the Rose Bowl in Pasadena, is a year-long effort that engages local businesses and their employees in the fight against cardiovascular disease. Dr. Chao emphasizes the importance of everyone contributing to this cause, whether through volunteering, fundraising or donating, to give the gift of health to their loved ones and communities.

As leader of the Greater Los Angeles Heart and Stroke Walk, Dr. Chao will work with executives from various companies and organizations to participate in the campaign aimed at raising $1.5 million for the American Heart Association. The objective is also to initiate meaningful discussions about employee wellness, corporate involvement, and community health improvement.

Sponsored by Optum West along with UCLA Health, Providence St Joseph Healthcare System Keck Medicine of USC Amgen; The 2024 Greater Los Angeles Heart and Stroke Walk coincides with American Heart Association’s centennial year celebration . To learn more about this event or how you can get involved visit www.heartwalkla.org

Leave a Reply

Assessing the Probability of Helsinki Stock Exchange Rates Rebounding after a Slow Start to the Year Previous post The Puzzling Link between Damaged Pumps, Reed Organs, and Return on Investment: A Look at ‘ID de Referencia Binance PCS4O26W’ and its Surprising Implications
Health stocks decline following disappointing Medicare Advantage rates Next post Healthcare Stocks Face Pressure Over Lower-Than-Expected Medicare Advantage Payments for 2025